266 related articles for article (PubMed ID: 15690087)
1. SOCS2 negatively regulates growth hormone action in vitro and in vivo.
Greenhalgh CJ; Rico-Bautista E; Lorentzon M; Thaus AL; Morgan PO; Willson TA; Zervoudakis P; Metcalf D; Street I; Nicola NA; Nash AD; Fabri LJ; Norstedt G; Ohlsson C; Flores-Morales A; Alexander WS; Hilton DJ
J Clin Invest; 2005 Feb; 115(2):397-406. PubMed ID: 15690087
[TBL] [Abstract][Full Text] [Related]
2. Knock your SOCS off!
Leroith D; Nissley P
J Clin Invest; 2005 Feb; 115(2):233-6. PubMed ID: 15690080
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of cytokine signalling and regulation of growth hormone action.
Greenhalgh CJ; Alexander WS
Growth Horm IGF Res; 2004 Jun; 14(3):200-6. PubMed ID: 15125881
[TBL] [Abstract][Full Text] [Related]
5. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation.
Goldshmit Y; Walters CE; Scott HJ; Greenhalgh CJ; Turnley AM
J Biol Chem; 2004 Apr; 279(16):16349-55. PubMed ID: 14764607
[TBL] [Abstract][Full Text] [Related]
6. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
8. Role of SOCS2 in growth hormone actions.
Turnley AM
Trends Endocrinol Metab; 2005 Mar; 16(2):53-8. PubMed ID: 15734145
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness.
Ransome MI; Goldshmit Y; Bartlett PF; Waters MJ; Turnley AM
Eur J Neurosci; 2004 Apr; 19(8):2069-79. PubMed ID: 15090034
[TBL] [Abstract][Full Text] [Related]
11. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b).
Greenhalgh CJ; Bertolino P; Asa SL; Metcalf D; Corbin JE; Adams TE; Davey HW; Nicola NA; Hilton DJ; Alexander WS
Mol Endocrinol; 2002 Jun; 16(6):1394-406. PubMed ID: 12040024
[TBL] [Abstract][Full Text] [Related]
12. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling.
Greenhalgh CJ; Metcalf D; Thaus AL; Corbin JE; Uren R; Morgan PO; Fabri LJ; Zhang JG; Martin HM; Willson TA; Billestrup N; Nicola NA; Baca M; Alexander WS; Hilton DJ
J Biol Chem; 2002 Oct; 277(43):40181-4. PubMed ID: 12208853
[TBL] [Abstract][Full Text] [Related]
13. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
[TBL] [Abstract][Full Text] [Related]
14. In vivo regulation of growth hormone-stimulated gene transcription by STAT5b.
Woelfle J; Rotwein P
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E393-401. PubMed ID: 14761873
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling.
Turnley AM; Faux CH; Rietze RL; Coonan JR; Bartlett PF
Nat Neurosci; 2002 Nov; 5(11):1155-62. PubMed ID: 12368809
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
17. Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation.
Hong-Brown LQ; Brown CR; Cooney RN; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E63-72. PubMed ID: 12644450
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
[TBL] [Abstract][Full Text] [Related]
19. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
[TBL] [Abstract][Full Text] [Related]
20. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
